Literature DB >> 25004226

Benchmarking biotech and pharmaceutical product development.

Donald L Drakeman1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25004226     DOI： 10.1038/nbt.2947

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

Review 1.  The importance of new companies for drug discovery: origins of a decade of new drugs.

Authors:  Robert Kneller
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

Review 2.  Lessons from 60 years of pharmaceutical innovation.

Authors:  Bernard Munos
Journal:  Nat Rev Drug Discov       Date:  2009-12       Impact factor: 84.694
  2 in total
  2 in total

1.  The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.

Authors:  K D S Fernald; H P G Pennings; J F van den Bosch; H R Commandeur; E Claassen
Journal:  PLoS One       Date:  2017-02-23       Impact factor: 3.240

Review 2.  Bridging academic science and clinical research in the search for novel targeted anti-cancer agents.

Authors:  Alex Matter
Journal:  Cancer Biol Med       Date:  2015-12       Impact factor: 4.248
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.